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Summary. Rotavirus vaccine was developed using the most prominent G and P genotypes circulating in children population. 
Therefore, severe gastroenteritis has been reduced around the world. This study investigated the G and P rotavirus genotypes 
circulating in children from two hospitals in the city of Chihuahua, Mexico. Additionally, polyclonal antibodies against 
Rotavirus Wa strain were used to determine their homotypic and heterotypic reactivity to both P[8] and P[4] genotypes. G1, G2, 
and G3 VP7 genotypes and P[8] and P[4] VP4 genotypes were detected in common and uncommon combinations as well as 
mixed infectious. The predominant combination was G1P[8]. Phylogenetic analysis of VP4 gene revealed the presence of 
P[8]-1 and P[8]-3 lineages of P[8] genotype and P[4]-5 lineage of P[4] genotype. All but five G1P[8] rotavirus were detected 
by polyclonal anti-Rotavirus Wa strain. Mutation analysis revealed differences in three of the four neutralizing epitopes previ-
ously reported to VP8* subunit of VP4 protein. Results of this study offer insights over genetic variants of field rotavirus that 
could be detected in a homotypic and heterotypic way by antibodies elicited to rotavirus with P[8] genotype. [Int Microbiol 
2016; 19(1):27-32] 
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Introduction
Rotavirus is the most important cause of viral gastroenteritis 
in humans. Annually, rotavirus is responsible for 197,000-
233,000 deaths in children less than five years of age mainly 
in developing countries [25]. Rotavirus (family Reoviridae, 
subfamily Sedoreovirinae, genus Rotavirus, species Rotavi-
rus A) is a nonenveloped virion composed by six structural 
proteins that form three concentric layers enclosing a genome 
of 11 segments of double-stranded RNA. The outer layer is 
composed by VP7 and VP4 proteins [9]. Based on these pro-
teins, rotavirus type A has been classified in a binary system. 
So far 27 G (VP7) and 37 P (VP4) genotypes have been iden-
tified [19,27].
Surveillance studies around the world, before and after the 
introduction of rotavirus vaccines have shown that P[8] is the 
main genotype circulating in human populations. To date, 
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P[8] genotype can be detected in levels of 70% of cases of 
infantile diarrhea, followed by P[4] that account nearly 15% 
[22]. Frequently, P[8] genotype is detected in combination 
with G1, G3, G4, G8 or G9 genotypes, whereas P[4] mainly is 
detected in combination with G2 genotype. In less extension, 
these P[8] and P[4] genotypes can also be detected in combi-
nation with other G genotypes [3,13,17].
P[8] and P[4] genotypes have been extensively studied in 
nucleotide and amino acid sequence. These studies have 
showed that genetic diversity is frequent among rotavirus cir-
culating around the world. As a consequence, four lineages of 
P[8] (P[8]-1 to P[8]-4) and five lineages of P[4] (P[4]-1 to 
P[4]-5) have been detected with considerable intralineage and 
interlineage diversity [5,8,29]. Although P[8]-3 and P[4]-5 
lineages are prevalent around the world, new lineages could 
emerge through different mechanisms including mutations, 
reassortment or recombination [1,20,23]. Nine antigenic re-
gions have been established on the VP4 outer capsid protein 
that are responsible to elicit neutralizing antibodies. Four of 
these regions have been mapped on VP8* subunit (8–1 to 
8–4) and five on VP5* subunit (5–1 to 5–5) [6,7]. Genetic 
studies have revealed changes in amino acid sequence on 
these epitopes among rotavirus strains with the same geno-
type and few studies focused on the combined effect of these 
changes on the detection of rotavirus by antibodies [1,15,29]. 
In this study, G and P genotypes of rotavirus circulating in the 
city of Chihuahua, Mexico, were detected. In addition, poly-
clonal antibodies elicited against Rotavirus Wa strain were 
used to test the reactivity of the lineages detected and to deter-
mine whether changes in the amino acid sequence of P[4] and 
P[8] genotypes could influence the antigen-antibody reaction.
 
Materials and methods
 
Stool specimens. A total of 140 positive samples for rotavirus detected 
by polyacrylamide gel electrophoresis (PAGE) collected from 2004 to 2011 
from children younger than five years of age were used in this study. All 
samples were collected from Chihuahua General Hospital Dr. Salvador Zubi-
ran and the Children’s Hospital from the city of Chihuahua, State of Chihua-
hua, northern Mexico. The fecal specimens were stored at –20 °C. 
Reverse transcription polymerase chain reaction (RT-PCR). 
Viral RNA was purified from 20% stools suspension in phosphate-buffered 
saline (PBS) by using TRI reagent (Molecular Research Center Inc., Cincin-
nati, OH, USA) following the manufacturer’s protocol. G and P genotypes 
were detected using the set of specific primers for G1-G4, P[8] and P[4] 
genotypes previously reported [10,11]. 
Sequencing and phylogenetic analysis of VP8* subunit. A 
PCR product of 762 bp of gene 4 using PA1 and PC2 primers was cloned and 
sequenced in the plasmid pGEM-T using the pGEM®-T Vector System I 
(Promega, Madison, WI, USA) [4]. The nucleotide sequence was determined 
using an automated system (Perkin Elmer/Applied Biosystem, CA, USA) at 
the Institute of Biotechnology of the National Autonomous University of 
Mexico (IBT-UNAM). The sequence analysis was done using CLUSTALW/
BioEdit sequence alignment Version 7.0 [12] and MEGA Version 6.0 soft-
ware [24]. The VP4 nucleotide and amino acid sequences included in this 
study were submitted to the GenBank database under accession numbers 
JX012330 to JX012347. The GenBank accesion numbers of VP4 gene used 
in sequence analysis were HQ585864 to HQ585866, FJ665380 to FJ6653091, 
M96825, JN849113, EU045252, and DQ492672. 
Polyclonal antibodies. The whole Rotavirus Wa strain were used to 
produce polyclonal antibodies. Polyclonal antibodies against a mixture of 
whole Rotavirus strains Wa, DS-1, ST3, SA11 and YM, here denominated 
anti-RVs (kindly provided by Carlos F. Arias, IBT-UNAM, Mexico) were 
used to detect rotavirus in specimen samples. 
Enzyme-linked immunsorbent assay (ELISA). Microtiter plates 
(Costar, NY, USA) were coated with goat polyclonal anti-RVs diluted in 
carbonate-bicarbonate buffer pH 9.6 and incubated overnight at 4 °C. After 
two washing with PBS, the plates were blocked with 5% non-fat dry milk in 
PBS at 37 °C for 1.5 h. After four washes with PBS-Tween 0.1% (washing 
buffer), 20% fecal suspensions from children with gastroenteritis containing 
P[8] or P[4] rotavirus were added in duplicate. Fecal samples without rotavi-
rus were used as negative controls. The plates were then incubated at 37 °C 
for 2 h, and after washing four times, rabbit polyclonal anti-Rotavirus Wa 
strain was added and incubated at 37 °C for 1 h. After four washes, peroxi-
dase-conjugated protein A (Amersham, Buckinghamshire, UK) was added 
and incubated at 37 °C for 1 h. The plates were then washed four times and 
the ABTS (2,2′-azino-bis[3-ethylbenzothiazoline-6-sulphonic acid]) peroxi-
dase substrate (KPL, Gaithersburg, MD, USA) was added and incubated at 37 
°C for 30 min. The absorbance at 405 nm was measured using an automatic 
microplate reader (Digital and Analog Systems, Roma, Italy). The cutoff 
value was defined as the mean of the control negative OD 405 nm values plus 
three standard deviations.
Results
G and P genotyping. Of the total samples, two speci-
mens positive by electrophoresis were typed as rotavirus 
group C, and 138 (98.5%) were assigned as G and P geno-
types, respectively. Of the latter, both genotypes were detect-
ed in 128 (92.7%). The most prevalent combination was 
G1P[8] with 57.85%, and G2P[4] genotype was detected in a 
small proportion (2.86%) of the specimens tested. However, 
either P[8] or P[4] were found in 133 specimens including 
samples with mixed infections of both genotypes (Table 1).
VP4 lineages. To determine the genetic diversity of rota-
virus belonging to the VP4 genotypes detected, 33 VP4 genes 
of the VP8* subunit were analyzed. Of these, 25 samples of 
P[8] genotype grouped into two lineages; 5 of them had 97.2–
98% identity with the Wa strain of P[8]-1 lineage, and 20 had 
98–99.6% identity with the Dhaka 16-03 Bangladesh strain of 
P[8]-3 lineage. Identity of P[8]-1 and P[8]-3 lineages used in 
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this study ranged from 93.6 to 91.6% (Fig. 1). In turn, eight 
P[4] rotavirus grouped into the P[4]-5 lineage with high iden-
tity to each other, ranging from 98.8 to 100% identity with the 
PY05SR1297 Paraguay strain of P[4]-5 lineage (Fig. 1). Iden-
tity of amino acids between P[8] and P[4] lineages was in or-
der of 85.6 to 90%. 
ELISA of field rotavirus. To evaluate the antigenicity 
of genotypes detected, 94 fecal samples positive to Rotavirus 
type A with sufficient material were further subjected to ELI-
SA. Both P[4] and P[8] genotypes were present in the fecal 
specimens. Of the 94 fecal specimens, P[8] was present in 63 
(67%), P[4] in 18 (19.1%), and mixed P[4] and P[8] in 13 
(13.9%). All specimens carried P[4] were detected, however, 
all but 5 (5.3%) specimens carried G1P[8] genotype were de-
tected by these antibodies (Table 2).  
Comparison of P[8] and P[4] antigenic regions 
of VP8* subunit. The genetic variation into rotavirus was 
made using 33 samples randomly selected. This comparison 
was made with the prototype Rotavirus Wa strain and the Ro-
tarix vaccine. The study of the 33 sequences analyzed revealed 
58 variations in the VP8* subunit of VP4 when they were com-
pared with VP8* sequence of Rotavirus Wa strain. The analysis 
of all changes showed that 37 amino acid substitutions were 
between residues with similar properties. In addition, 15 charge 
amino acid changes (Y19H, E28K, T75K, N89D, N113T/D/S, 
D116N, S131R/E, D133E/S, D135N, N160D, N193D, C215R, 
K245R/T/N, N250K and E251K) were identified as well as 6 
changes of residues with possible structural implications (con-
formational flexibility or constrain) on the proteins (G38S, 
P71S, P114Q, G145S, G195N and P236S). Specific compari-
son of the amino acid residues in antigenic epitopes of VP8* 
subunit between Rotavirus Wa and P[8] and P[4] genotypes of 
field rotavirus showed differences on 3 of the 4 epitopes. In ad-
dition, the analyses on the epitope 8-1 and 8-3 identified 5 and 
8 changes respectively, while rotavirus with P[4] genotype had 
differences on the epitope 8-4. The alignment between Rotavi-
rus Wa and Rotarix vaccine revealed consensus in the antigenic 
domains of the VP8* subunit.
Table 1. Prevalence of VP7 and VP4 rotavirus genotypes in feces from 140 positive samples from children 
under five from two hospitals in the city of Chihuahua, Mexico
G and P-type                           Strain N %
Common types   
G1P[8] 81 57.85
G3P[8] 5 3.57
G2P[4] 4 2.86
Uncommon types
G1P[4] 12 8.57
G2P[8] 1 0.71
G3P[4] 1 0.71
Mixed infections
       G1P[8]P[4] 17 12.14
       G2P[8]P[4] 2 1.43
       G3P[8]P[4] 4 2.86
           G1G3P[8]P[4] 1 0.71
G or P non typable
          NEGP[8]P[4] 1 0.71
     NEG P[8] 4 2.86
   G1 NEG 5 3.57
Group C
     NEG NEG 2 1.43
Total 140 100
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Discussion
Traditionally, epidemiological studies based on surface pro-
teins VP7 and VP4 have classified rotavirus in a binary sys-
tem, identifying multiple genotypes combinations G/P [19]. 
Despite the great variability of this pathogen, G1P[8], G2P[4], 
G3P[8], G4P[8], G9P[8] genotypes have been frequently de-
tected around the world and G12P[8] genotype in a lesser ex-
tension [13,17,21]. In this study, P[8] and P[4] genotypes 
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Fig. 1. Phylogenetic tree constructed from VP8* subunit amino acid sequences of the P[8] and P[4] rotavirus genotypes using neighbor-joining method 
(MEGA v6.0) with bootstrap analysis of 1000 replicates. Stool specimens selected from 140 positive samples for rotavirus from children under five from two 
hospitals in the city of Chihuahua, Mexico. Bar indicates 1% amino acid difference.
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were detected in more than 95% of the rotavirus analyzed, 
indicating the same prevalence of these genotypes worldwide 
[1,13,23]. In addition, phylogenetic analysis of P[8] and P[4] 
genotypes have shown four and five lineages respectively. Of 
them, P[8]-3 and P[4]-5 lineages are prominent around the 
world [5,8,15,23]. In this study lineage P[8]-3 was detected in 
80% of rotavirus with P[8] genotype and, to a lesser extent, in 
the lineage P[8]-1, which corresponds to the lineage present 
in the Rotarix vaccine. Moreover, lineage P[4]-5 was identi-
fied in all samples with P[4] genotype, which corresponds to 
the lineage of this genotype with more incidence worldwide 
[8,26]. After the introduction of the vaccine, several reports 
have revealed the need of continued epidemiological surveil-
lance of rotavirus to understand the impact of genetic varia-
tion in the efficiency of the vaccine [2,16,18,23,29]. 
In this study, 94.7% of the samples analyzed were recog-
nized by antibodies against Rotavirus Wa strain. These results 
are in accordance with previous reports that showed homo-
typic and heterotypic antibody reactivity between strains with 
different genotype [28]. Note that all rotavirus with P[4] gen-
otype were recognized by these antibodies. However, five 
with P[8] genotype did not show reactivity, which suggests 
that amino acid changes in regions of VP8* subunit could in-
terfere with antibody recognition and consequently could 
generate strains of rotavirus that elude the immunity generat-
ed by vaccination. The sequence analysis conducted in this 
study revealed both amino acid changes with similar proper-
ties and amino acid changes that could be related to physico-
chemical and structural alterations in the VP8* subunit.
Likewise, the analysis of variations between the sequenc-
es analyzed revealed that residues from 106 to 199 had the 
majority of amino acid changes of VP8*. Note that, in this 
region, there are epitopes responsible for neutralizing anti-
bodies previously reported [6,7]. However, despite amino 
acid changes present in the VP8* subunit, these antibodies 
maintained the reactivity in the majority of the specimens. Se-
quence analysis of two negative samples by ELISA showed 
one specific amino acid substitution (N113T), when they were 
compared with vaccine strain or genetic variants (N113D/S) 
of positive samples, specifically into the epitope 8-3 on the 
VP8* subunit. This result is in contrast with previous reports 
that have revealed that single amino acid substitutions in these 
regions can alter the antigenic characteristics of VP4 [14]. 
Therefore, it is necessary to extend the studies of antigenic 
variability in field rotavirus to establish the possible role of 
putative surface residues as N/D/S at 113 position as well as 
genetic variants as N113T or other residues with conforma-
tional implications to elude antibody recognition. 
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